Cell and Gene Manufacturing and Logistics

  1. Hormuz Deal Brings Cautious Relief To Pharma Packaging Supply Chains 6/19/2026

    Restrictions and fear on the Hormuz Strait have fractured supply chains, especially for primary materials used in pharmaceutical packaging.

  2. Upstream Bioprocess Equipment For Commercial Manufacturing 6/18/2026

    Transform your bioprocessing workflow with intelligent, user-friendly systems that combine precision engineering with operational excellence for superior outcomes.

  3. Single-Use Bioreactors For Cell Culture, Fermentation, And Commercial Manufacturing 6/18/2026

    Enhance your bioprocessing with single-use bioreactors that offer broad compatibility, reduced turnaround times, and consistent product yield through innovative design and flexible scalability.

  4. Generate Stable High-Producing Clones In 14 Weeks 6/18/2026

    Rising complexity is putting pressure on cell line development. Discover a streamlined approach that enables rapid generation of stable clones with strong titers and long-term consistency.

  5. Creative Chromatography Solutions For Complex Small Molecules 6/18/2026

    Chromatographic modeling enables smarter purification. Discover how digital tools, fraction mapping, and expert execution can improve yield for the most challenging small-molecule separations.

  6. Where Speed Meets Complexity In Bioprocess Development 6/18/2026

    Bioprocessing faces mounting pressure to compress timelines, especially for mAbs, while complex modalities like bispecifics and gene therapies introduce technical challenges. Process intensification, scale-up translation, and comparability risks remain critical hurdles.

  7. The Scale-Up Of A Transient rAAV8 Production Process 6/18/2026

    New approaches to suspension cell culture and process scaling enable consistent, high-titer rAAV production. Gain insight into a clearer path to scalable manufacturing for gene therapy pipelines.

  8. Is Your AI Model Trustworthy And Credible In GMP Processes? 6/17/2026

    Credibility and trustworthiness in AI models are related but distinct attributes. If you're using them in GMP manufacturing, you should understand the difference.

  9. The Manufacturing Reckoning Behind CAR-T's Hottest Race 6/16/2026

    In vivo CAR-T scales patient access and cuts timelines but turns biological hurdles into complex manufacturing demands. Precise assays and tight raw material controls are vital for regulatory success.

  10. How To Choose The Right CDMO 6/16/2026

    Advanced therapy manufacturing requires deep biological expertise. Choosing a partner with translational experience and a robust CMC strategy is vital to navigating complex regulatory reviews.